Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 29 | 2023 | 1864 | 5.060 |
Why?
|
Elasticity Imaging Techniques | 10 | 2021 | 388 | 2.680 |
Why?
|
End Stage Liver Disease | 3 | 2021 | 314 | 1.370 |
Why?
|
Fatty Liver | 5 | 2021 | 728 | 1.010 |
Why?
|
Liver Diseases | 3 | 2021 | 1252 | 0.790 |
Why?
|
Lipoproteins, VLDL | 3 | 2018 | 201 | 0.790 |
Why?
|
Liver Transplantation | 4 | 2021 | 2117 | 0.770 |
Why?
|
Ceruloplasmin | 3 | 2015 | 56 | 0.730 |
Why?
|
Hepatolenticular Degeneration | 3 | 2015 | 69 | 0.720 |
Why?
|
Adenosine Deaminase | 2 | 2021 | 241 | 0.700 |
Why?
|
Keratin-18 | 2 | 2016 | 38 | 0.680 |
Why?
|
Tissue and Organ Procurement | 2 | 2019 | 890 | 0.590 |
Why?
|
Liver Function Tests | 3 | 2016 | 528 | 0.560 |
Why?
|
Serum | 1 | 2017 | 212 | 0.560 |
Why?
|
Primary Health Care | 3 | 2021 | 4551 | 0.550 |
Why?
|
Lipase | 1 | 2018 | 315 | 0.540 |
Why?
|
Rifamycins | 1 | 2015 | 25 | 0.540 |
Why?
|
Lactulose | 1 | 2015 | 33 | 0.540 |
Why?
|
Hepatitis C, Chronic | 4 | 2012 | 1027 | 0.530 |
Why?
|
Clinical Laboratory Techniques | 2 | 2019 | 740 | 0.530 |
Why?
|
Data Mining | 1 | 2020 | 537 | 0.510 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 719 | 0.510 |
Why?
|
Hepatic Encephalopathy | 1 | 2015 | 139 | 0.490 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1675 | 0.480 |
Why?
|
Liver | 9 | 2021 | 7470 | 0.470 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2021 | 2211 | 0.460 |
Why?
|
Nutrition Assessment | 1 | 2016 | 723 | 0.450 |
Why?
|
Patient Readmission | 2 | 2015 | 3111 | 0.390 |
Why?
|
Gastrointestinal Agents | 1 | 2015 | 494 | 0.380 |
Why?
|
Liver Neoplasms | 3 | 2021 | 4249 | 0.360 |
Why?
|
Malnutrition | 1 | 2016 | 625 | 0.360 |
Why?
|
Alanine Transaminase | 3 | 2012 | 592 | 0.350 |
Why?
|
Fibrosis | 3 | 2021 | 2026 | 0.340 |
Why?
|
Hepatitis B Vaccines | 1 | 2010 | 194 | 0.340 |
Why?
|
Predictive Value of Tests | 8 | 2020 | 15056 | 0.330 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11695 | 0.330 |
Why?
|
Organ Transplantation | 1 | 2019 | 1135 | 0.330 |
Why?
|
Guideline Adherence | 3 | 2015 | 2266 | 0.330 |
Why?
|
Preventive Medicine | 1 | 2010 | 263 | 0.320 |
Why?
|
Weight Loss | 2 | 2016 | 2604 | 0.310 |
Why?
|
Interleukins | 1 | 2012 | 791 | 0.300 |
Why?
|
Rural Health Services | 1 | 2011 | 379 | 0.300 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1952 | 0.300 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2008 | 93 | 0.300 |
Why?
|
ROC Curve | 6 | 2021 | 3528 | 0.290 |
Why?
|
Preventive Health Services | 1 | 2011 | 575 | 0.280 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15530 | 0.260 |
Why?
|
Biopsy | 6 | 2021 | 6756 | 0.250 |
Why?
|
Hepacivirus | 1 | 2012 | 1372 | 0.250 |
Why?
|
Male | 34 | 2023 | 349538 | 0.250 |
Why?
|
Hepatitis B | 1 | 2010 | 695 | 0.250 |
Why?
|
Humans | 51 | 2023 | 742088 | 0.240 |
Why?
|
Female | 34 | 2022 | 379592 | 0.240 |
Why?
|
Linear Models | 4 | 2021 | 5948 | 0.240 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 774 | 0.240 |
Why?
|
Macrophages | 2 | 2020 | 5655 | 0.240 |
Why?
|
Middle Aged | 26 | 2023 | 213127 | 0.230 |
Why?
|
Electronic Health Records | 1 | 2020 | 4440 | 0.230 |
Why?
|
Viral Load | 1 | 2012 | 3292 | 0.230 |
Why?
|
Hepatitis B, Chronic | 1 | 2007 | 393 | 0.220 |
Why?
|
Prednisone | 1 | 2008 | 1567 | 0.220 |
Why?
|
Hip Fractures | 1 | 2011 | 954 | 0.220 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5724 | 0.210 |
Why?
|
Health Services Research | 1 | 2010 | 1834 | 0.210 |
Why?
|
Osteoporosis | 1 | 2011 | 1581 | 0.200 |
Why?
|
Kupffer Cells | 1 | 2021 | 142 | 0.200 |
Why?
|
Risk Assessment | 7 | 2020 | 23320 | 0.200 |
Why?
|
Hospital Mortality | 1 | 2015 | 5310 | 0.190 |
Why?
|
Membrane Proteins | 1 | 2018 | 7873 | 0.190 |
Why?
|
Autocrine Communication | 1 | 2021 | 171 | 0.190 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11690 | 0.190 |
Why?
|
Polyethylene Glycols | 2 | 2019 | 1181 | 0.190 |
Why?
|
Quality Improvement | 1 | 2015 | 3738 | 0.180 |
Why?
|
Paracrine Communication | 1 | 2021 | 276 | 0.180 |
Why?
|
Hepatitis, Alcoholic | 1 | 2021 | 103 | 0.180 |
Why?
|
Presumed Consent | 1 | 2019 | 2 | 0.180 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1831 | 0.180 |
Why?
|
Algorithms | 1 | 2020 | 13853 | 0.180 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2211 | 0.170 |
Why?
|
Logistic Models | 5 | 2021 | 13403 | 0.170 |
Why?
|
Hepatic Stellate Cells | 1 | 2020 | 109 | 0.170 |
Why?
|
Prospective Studies | 11 | 2023 | 53187 | 0.170 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19862 | 0.160 |
Why?
|
Dietary Supplements | 1 | 2011 | 3294 | 0.160 |
Why?
|
Retrospective Studies | 10 | 2021 | 77098 | 0.160 |
Why?
|
Diet | 1 | 2016 | 7923 | 0.160 |
Why?
|
Body Mass Index | 1 | 2016 | 12695 | 0.160 |
Why?
|
Heart Failure | 1 | 2022 | 10856 | 0.160 |
Why?
|
Confidence Intervals | 2 | 2015 | 2970 | 0.150 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12242 | 0.150 |
Why?
|
Health Policy | 1 | 2010 | 2657 | 0.150 |
Why?
|
Angina, Unstable | 1 | 2022 | 926 | 0.150 |
Why?
|
Aged | 15 | 2023 | 162944 | 0.140 |
Why?
|
Germany | 1 | 2018 | 860 | 0.140 |
Why?
|
Israel | 1 | 2019 | 795 | 0.140 |
Why?
|
Sodium | 1 | 2021 | 1627 | 0.140 |
Why?
|
Odds Ratio | 3 | 2015 | 9846 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 2 | 2015 | 1162 | 0.140 |
Why?
|
Adult | 19 | 2023 | 213712 | 0.140 |
Why?
|
Area Under Curve | 2 | 2021 | 1653 | 0.140 |
Why?
|
Risk Factors | 8 | 2022 | 72145 | 0.130 |
Why?
|
Hospitalization | 1 | 2015 | 10232 | 0.130 |
Why?
|
Survival Analysis | 3 | 2019 | 10248 | 0.130 |
Why?
|
Lipoproteins, LDL | 1 | 2018 | 628 | 0.130 |
Why?
|
Waiting Lists | 1 | 2019 | 692 | 0.120 |
Why?
|
Quality of Life | 1 | 2016 | 12730 | 0.120 |
Why?
|
Fructose | 1 | 2016 | 288 | 0.120 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 224 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 314 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 506 | 0.120 |
Why?
|
Chronic Disease | 3 | 2019 | 9144 | 0.120 |
Why?
|
Lipoproteins, HDL | 1 | 2018 | 637 | 0.120 |
Why?
|
Vibration | 1 | 2015 | 325 | 0.110 |
Why?
|
Fibroblast Growth Factors | 1 | 2019 | 879 | 0.110 |
Why?
|
Hepatocytes | 1 | 2020 | 1209 | 0.110 |
Why?
|
Biopsy, Needle | 2 | 2016 | 1640 | 0.110 |
Why?
|
Cost-Benefit Analysis | 2 | 2016 | 5385 | 0.110 |
Why?
|
Insulin Resistance | 2 | 2016 | 3861 | 0.100 |
Why?
|
Ultrasonography | 2 | 2015 | 5978 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2593 | 0.100 |
Why?
|
Western Australia | 1 | 2011 | 41 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 431 | 0.100 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1901 | 0.100 |
Why?
|
Cold Ischemia | 1 | 2011 | 65 | 0.100 |
Why?
|
Hepatitis B Antigens | 1 | 2010 | 40 | 0.100 |
Why?
|
Genotype | 2 | 2018 | 12946 | 0.090 |
Why?
|
Clinical Enzyme Tests | 1 | 2010 | 115 | 0.090 |
Why?
|
Ribavirin | 1 | 2012 | 395 | 0.090 |
Why?
|
Cell-Derived Microparticles | 1 | 2012 | 168 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 638 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2016 | 62966 | 0.090 |
Why?
|
Frail Elderly | 1 | 2015 | 691 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2015 | 544 | 0.090 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 577 | 0.090 |
Why?
|
Boston | 4 | 2016 | 9305 | 0.080 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 418 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1679 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2012 | 2978 | 0.080 |
Why?
|
Interferons | 1 | 2012 | 704 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2410 | 0.080 |
Why?
|
Cohort Studies | 4 | 2021 | 40450 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3862 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 24913 | 0.080 |
Why?
|
Inflammation | 3 | 2015 | 10578 | 0.080 |
Why?
|
Prognosis | 3 | 2021 | 29010 | 0.080 |
Why?
|
Interferon-alpha | 1 | 2012 | 895 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3510 | 0.080 |
Why?
|
Radiography | 1 | 2019 | 7010 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2018 | 3760 | 0.080 |
Why?
|
Registries | 2 | 2016 | 8077 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17400 | 0.080 |
Why?
|
Hepatitis B e Antigens | 1 | 2007 | 133 | 0.070 |
Why?
|
Hyaluronic Acid | 1 | 2010 | 489 | 0.070 |
Why?
|
Hepatitis B virus | 1 | 2010 | 513 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9679 | 0.070 |
Why?
|
Carrier State | 1 | 2010 | 518 | 0.070 |
Why?
|
Diphosphonates | 1 | 2011 | 625 | 0.070 |
Why?
|
Death | 1 | 2011 | 675 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15494 | 0.070 |
Why?
|
Ubiquitin | 1 | 2011 | 849 | 0.070 |
Why?
|
United States | 4 | 2016 | 69693 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2019 | 12017 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7276 | 0.060 |
Why?
|
Drug Utilization | 1 | 2011 | 1181 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14720 | 0.060 |
Why?
|
Life Style | 1 | 2016 | 3824 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2011 | 1333 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10372 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4391 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1533 | 0.060 |
Why?
|
Age Factors | 2 | 2013 | 18355 | 0.060 |
Why?
|
DNA, Viral | 1 | 2010 | 2224 | 0.060 |
Why?
|
Citrates | 1 | 2023 | 131 | 0.060 |
Why?
|
Disease Progression | 2 | 2020 | 13256 | 0.060 |
Why?
|
Citric Acid | 1 | 2023 | 126 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1737 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6608 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 2354 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3300 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2739 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11363 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2010 | 1411 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6575 | 0.050 |
Why?
|
Tissue Donors | 1 | 2011 | 2205 | 0.050 |
Why?
|
Drug Prescriptions | 1 | 2011 | 1636 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6294 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5851 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2011 | 2049 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12344 | 0.050 |
Why?
|
Thioacetamide | 1 | 2020 | 15 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2021 | 251 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 7716 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57683 | 0.050 |
Why?
|
Apolipoproteins B | 1 | 2021 | 373 | 0.050 |
Why?
|
Hepatitis C | 1 | 2010 | 1582 | 0.040 |
Why?
|
Medication Adherence | 1 | 2011 | 2055 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 931 | 0.040 |
Why?
|
Calcium | 1 | 2011 | 5753 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2021 | 425 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3211 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2714 | 0.040 |
Why?
|
Glucose-6-Phosphatase | 1 | 2016 | 73 | 0.040 |
Why?
|
Lipoproteins | 1 | 2021 | 876 | 0.040 |
Why?
|
Transcription Factors | 1 | 2016 | 12164 | 0.040 |
Why?
|
Factor VII | 1 | 2015 | 139 | 0.030 |
Why?
|
Lipogenesis | 1 | 2016 | 212 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1656 | 0.030 |
Why?
|
Phagocytosis | 1 | 2020 | 1538 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5238 | 0.030 |
Why?
|
Vegetables | 1 | 2020 | 1179 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23387 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2895 | 0.030 |
Why?
|
Time Factors | 2 | 2011 | 40054 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 825 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2016 | 577 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2012 | 12958 | 0.030 |
Why?
|
Dietary Fats | 1 | 2020 | 2017 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 2011 | 222 | 0.020 |
Why?
|
Primary Graft Dysfunction | 1 | 2011 | 93 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 25575 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 21719 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8662 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29087 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 207 | 0.020 |
Why?
|
Hypertension, Portal | 1 | 2010 | 220 | 0.020 |
Why?
|
Immunoassay | 1 | 2011 | 752 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3520 | 0.020 |
Why?
|
California | 1 | 2011 | 1400 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15194 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2011 | 1025 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 859 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 16678 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9715 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3766 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3527 | 0.010 |
Why?
|
Animals | 3 | 2020 | 168561 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7770 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5975 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14554 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81045 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18006 | 0.010 |
Why?
|
Graft Survival | 1 | 2011 | 3733 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 56350 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2012 | 4379 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4438 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39004 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12773 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20086 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 35342 | 0.000 |
Why?
|
Concepts
(250)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_